Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × Inosine × Clear all

NCT06355024 2025-07-18

Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

Phase 2 Completed

Triple Negative Breast Neoplasms